Related Experiment Video
Updated: Aug 16, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[New antiretroviral treatment modalities]
1Service des Maladies Infectieuses et Tropicales, UMR 145 VIH et Maladies Associées Hôpital Gui de Chauliac, 34295 Montpellier. j-reynes@chumontpellier.fr
Presse Medicale (Paris, France : 1983)
|July 20, 2005
Summary
New HIV treatments in 2005 utilize advanced antiretrovirals and single-tablet regimens, including novel protease and entry inhibitors, to improve patient outcomes and manage treatment resistance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Context:
- Advancements in HIV/AIDS treatment in 2005.
- Emergence of novel antiretroviral drug classes and combination therapies.
Purpose:
- To review new treatment modalities for HIV infection available in 2005.
- To discuss new antiretroviral drugs and strategies for their use.
Summary:
- New single-tablet regimens combining reverse transcriptase inhibitors (e.g., abacavir/lamivudine, tenofovir/emtricitabine) minimize mitochondrial toxicity.
- Ritonavir-boosted protease inhibitors (PIs) like atazanavir and fosamprenavir offer improved tolerance and resistance profiles, with new agents (tipranavir, TMC114) targeting resistant strains.
- Entry inhibitors (CCR5 antagonists) and enfuvirtide (fusion inhibitor) represent promising new classes for treatment-experienced patients, including those with prior failures.
Impact:
- Simplification of treatment regimens and potential for treatment interruptions in successfully managed patients.
- Necessity of thorough virological-pharmacological assessment for non-responders, emphasizing access to novel therapeutics and drug classes.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...